Supplements and medicines share shelf space in the same shops and often look alike in a capsule. The legal frameworks behind them are not alike at all, and the difference explains most of what confuses people about labels.
The two categories were separated deliberately
In the United States, dietary supplements are treated as a subcategory of food rather than as drugs. Ingredients such as vitamins, minerals, botanicals and amino acids fall inside that definition.
A drug, by contrast, is a product intended to diagnose, treat, cure or prevent disease. The intended use, stated through the labelling, is what places a product in one bucket or the other.
That single classification decision then determines the evidence requirements, the review timing and the permitted claims.
Review happens after sale rather than before it
A new drug reaches the market only after a regulator has examined trial data and agreed the product works and is acceptably safe for its stated use.
A supplement carries no equivalent pre-market approval. The manufacturer is responsible for ensuring the product is safe and that its labelling is truthful, and the regulator's role is largely to act afterwards if problems surface.
The practical consequence is that a supplement on a shelf has not necessarily been assessed by anyone outside the company selling it.
Structure-function wording is a legal boundary
Supplement labels tend to use a distinctive register: supports, maintains, contributes to, helps promote. This is not marketing squeamishness.
Claims about normal structure or function of the body are permitted in that category. Claims that a product treats or prevents a named disease are not, because such a claim would reclassify the product as a drug.
Reading the verb on a label therefore tells you which regulatory box the product sits in, which is often more informative than the front-of-pack imagery.
Manufacturing rules are separate from efficacy rules
Good manufacturing practice requirements do apply to supplements, covering identity, purity, strength and composition.
Those rules address whether the bottle contains what the label says, in the stated amount. They say nothing about whether the ingredient does anything useful.
Third-party testing programmes exist for the same narrow reason, verifying contents rather than benefit.
Where this leaves an individual decision
Because the framework does not require proof of benefit, the evidence for any given supplement has to be assessed ingredient by ingredient rather than assumed from its presence on a shelf.
Interactions and dosing questions belong with a pharmacist or doctor, who can see the rest of what a person takes. That is the part no label is designed to answer.